About 40% of reported failures in MedTech can be attributed to materials, ranging from materials quality and appropriate selection to withstanding demanding performance requirements. When a sponsor notices a reported failure or complaint is associated with a device material, Chemva supports them by:
- Employing structured methodologies to uncover the underlying causes of product or process failures.
- Developing and evaluating effective corrective measures to address identified issues.
- Establishing and executing a structured plan to correct and prevent quality problems, ensuring alignment with regulatory requirements.

.png)





.webp)

.png)
